Strategic Partnerships The LAM Foundation actively collaborates with research partners and patient advocacy groups, including notable partnerships with TrilliumBiO and TSC Alliance. This presents opportunities to position complementary programs, co-sponsored patient education events, and joint fundraising initiatives to broaden reach and impact.

Research Funding With a strong track record of raising nearly $37 million and directing over $19 million to research, The LAM Foundation demonstrates high donor engagement and programmatic impact. Sales opportunities exist in providing grant management tools, donor CRM enhancements, or fundraising campaigns that align with translational research milestones.

Clinical Collaboration NHLBI recognizes The LAM Foundation as a model organization and the FDA has approved Rapamune thanks to their efforts. This indicates readiness for advanced clinical data collaboration, registry solutions, or technology to accelerate patient recruitment, consent, and real-world evidence collection.

Digital & Tech Enablement Current tech stack includes Salesforce, Microsoft 365, and web technologies, suggesting a potential need for nonprofit-focused CRM optimization, data integration, marketing automation, and secure patient-education portals to improve outreach and program efficiency.

Sustainability & Growth Revenue range of 10M-25M with 11-50 employees signals a mid-sized nonprofit capacity for scale. Opportunities exist in offering scalable fundraising platforms, grant management, and donor stewardship solutions to sustain long-term research investments and program expansion as they pursue earlier diagnosis and new therapies.